BR0107998A - Método para produção de um preparo antiviral imunotrópico - Google Patents

Método para produção de um preparo antiviral imunotrópico

Info

Publication number
BR0107998A
BR0107998A BR0107998-0A BR0107998A BR0107998A BR 0107998 A BR0107998 A BR 0107998A BR 0107998 A BR0107998 A BR 0107998A BR 0107998 A BR0107998 A BR 0107998A
Authority
BR
Brazil
Prior art keywords
producing
solution
dna
hyperchromatic
homogenate
Prior art date
Application number
BR0107998-0A
Other languages
English (en)
Inventor
Elli Nikolaevna Kaplina
Alexandra Yurievna Ladygina
Valery Yurievich Kaplin
Mikhail Yuriech Vainberg
Original Assignee
Elli Nikolaevna Kaplina
Alexandra Yurievna Ladygina
Valery Yurievich Kaplin
Mikhail Yuriech Vainberg
S R L Veritas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20242805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0107998(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elli Nikolaevna Kaplina, Alexandra Yurievna Ladygina, Valery Yurievich Kaplin, Mikhail Yuriech Vainberg, S R L Veritas filed Critical Elli Nikolaevna Kaplina
Publication of BR0107998A publication Critical patent/BR0107998A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/711Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO PARA PRODUçãO DE UM PREPARO ANTIVIRAL IMUNOTRóPICO". A invenção refere-se a uma indústria de produto químico farmacêutico, em particular um método para produzir um preparo imunotrópico exibindo uma atividade antiviral em relação aos vírus de RNA e de DNA. Com a finalidade de produzir o preparo inventivo, esturjão ou milt de salmão livre de gordura, ou um timo de bezerro, ou sangue de galinha, ou fígado de suíno é pulverizado e homogeneizado em uma solução salina de citrato. O homogeneizado produzido é incubado na presença de um detergente, uma solução clorada de cálcio sendo adicionada a uma temperatura elevada. Depois, o referido homogeneizado é tratado por ultra-som, um sorvente e detergente e concentrado, desse modo produzindo um sedimento amorfo branco de DNA, o qual possui as seguintes características: uma massa molecular variando de 270 a 500 kD, uma ação hipercromática não menor que 37%, um conteúdo de proteína menor que 1%. O sedimentado de DNA é seco e o pó obtido é diluído em uma solução aquosa dos seguintes metais de transição: Zn, Co, Mn, Sb, pelo qual uma solução a 1,5% esterilizada possuindo uma ação hipercromática igual a ou superior a 10% é obtida.
BR0107998-0A 2000-12-01 2001-04-24 Método para produção de um preparo antiviral imunotrópico BR0107998A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2000130036/14A RU2172632C1 (ru) 2000-12-01 2000-12-01 Способ получения иммунотропного противовирусного препарата
PCT/RU2001/000171 WO2002043740A1 (fr) 2000-12-01 2001-04-24 Procede de fabrication d'un produit antiviral immunotropique

Publications (1)

Publication Number Publication Date
BR0107998A true BR0107998A (pt) 2002-10-29

Family

ID=20242805

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107998-0A BR0107998A (pt) 2000-12-01 2001-04-24 Método para produção de um preparo antiviral imunotrópico

Country Status (8)

Country Link
EP (1) EP1338281B1 (pt)
AT (1) ATE321132T1 (pt)
AU (1) AU2001256888A1 (pt)
BR (1) BR0107998A (pt)
CA (1) CA2399310C (pt)
DE (1) DE60118175T2 (pt)
RU (1) RU2172632C1 (pt)
WO (1) WO2002043740A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2309759C1 (ru) * 2006-11-03 2007-11-10 Элли Николаевна Каплина Способ получения апирогенного иммуномодулятора
RU2519349C1 (ru) * 2013-02-26 2014-06-10 Государственное научное учреждение Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии Российской академии сельскохозяйственных наук (ГНУ ВНИВИПФиТ Россельхозакадемии) Способ комплексного лечения мастита у лактирующих коров
RU2739186C1 (ru) * 2020-04-21 2020-12-21 Александр Евгеньевич Ладыгин Способ получения противовирусного лекарственного средства

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
WO1993010793A1 (en) * 1991-12-03 1993-06-10 Jury Petrovich Vainberg Antivirus agent
US5547684A (en) * 1993-02-10 1996-08-20 Pharmec Company Cosmetic composition containing a DNA-sodium salt and methods of making and using the same
RU2005724C1 (ru) * 1993-04-29 1994-01-15 Юрий Петрович Вайнберг Способ производства натриевой соли дезоксирибонуклеиновой кислоты из животного сырья и установка для его осуществления
RU2043767C1 (ru) * 1993-05-24 1995-09-20 Научно-производственное предприятие "Фармэк" Способ подавления вич-инфекции
WO1994028153A2 (fr) * 1993-05-24 1994-12-08 Nauchno-Proizvodstvennoe Predpriyatie 'farmek' Adn de faible masse moleculaire tiree de laitance d'esturgeon, procede d'obtention de l'adn et preparation pharmaceutique a base de celui-ci
RU2041885C1 (ru) * 1993-05-31 1995-08-20 Научно-производственный центр "Фармзащита" МЗ РФ Способ получения порошка натриевой соли дезоксирибонуклеиновой кислоты из молок рыб
RU2055837C1 (ru) * 1994-05-31 1996-03-10 Научно-производственный центр "Фармзащита" Способ получения стерильного раствора натриевой соли дезоксирибонуклеиновой кислоты
RU2108797C1 (ru) * 1994-11-09 1998-04-20 Закрытое акционерное общество "Фаркавер" Способ получения антивирусного препарата на основе днк
WO1996009832A1 (fr) * 1994-09-29 1996-04-04 Nauchno-Proizvodstvennoe Predpriyatie 'farmek' Hybride d'adn-arn et preparation d'adn, procedes d'obtention dudit hybride et de ladite preparation a partir de laitance d'esturgeon, et compose pharmaceutique a base dudit hybride d'adn-arn
RU2136286C1 (ru) * 1996-01-22 1999-09-10 Каплина Элли Николаевна Противовирусное средство к рнк- и днк-содержащим вирусам
RU2158592C1 (ru) * 1999-12-29 2000-11-10 Каплина Элли Николаевна Противовирусное иммунотропное средство

Also Published As

Publication number Publication date
DE60118175D1 (de) 2006-05-11
WO2002043740A1 (fr) 2002-06-06
DE60118175T2 (de) 2007-01-25
CA2399310C (en) 2012-09-18
EP1338281A1 (en) 2003-08-27
CA2399310A1 (en) 2002-06-06
ATE321132T1 (de) 2006-04-15
EP1338281A4 (en) 2004-03-24
RU2172632C1 (ru) 2001-08-27
EP1338281B1 (en) 2006-03-22
AU2001256888A1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
ATE485371T1 (de) Varianten des menschlichen koagulationsfaktors vii
BR9915573A (pt) Processo de preparação de uma composição protéica e uma fórmula infantil contendo a mesma
ES2087156T3 (es) Metodos para la inactivacion de virus en composiciones farmaceuticas contaminadas por virus.
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
CY1110700T1 (el) Ανασυνδυασμενα αντισωματα αντι-cd30 και χρησεις αυτων
DE69928472D1 (de) Stabilisierte pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung
DK1301201T3 (da) Behandling af glycogenosis type II
DE69418403T2 (de) Verfahren zur Herstellung von Aminosäureteilchen
BR0007035A (pt) Métodos de controle de pragas de agrótis
AR029644A1 (es) Proteina aislada, polinucleotido aislado, celula huesped transgenica, metodo para controlar una plaga que no es de mamiferos, cultivo biologicamente puro
BR9807776A (pt) Processo para a preparação de um suplemento alimentìcio animal capaz de escoar à base de sal de metionina e o granulado assim obtenìvel
ES2113878T3 (es) Proteina c hibrida.
BR0107998A (pt) Método para produção de um preparo antiviral imunotrópico
PT94680A (pt) Processo para a obtencao de uma proteina tendo actividade de urato oxidase gene recombinante que a codifica vector de expressao portador deste gene microorganismos procariotas e celulas eucariotas transformados por este vector de expressao
BR9908500A (pt) Processo de peletização
WO2004064732A3 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
BR9002873A (pt) Composicao aquosa de condicionamento de cabelo e processo para aperfeicoar a elasticidade do cabelo
ATE336992T1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz- erkrankungen
ATE372687T1 (de) Verfahren zur verbesserung von proteinprodukten
ES2085767T3 (es) Aumento de la actividad catalitica de las ribozimas por un oligonucleotido facilitador proximo.
AR013886A1 (es) Proteinas utiles para tratar la obesidad y condiciones asociadas con la obesidad; composiciones farmaceuticas formuladas con dichas proteinas;compuestos polinucleoticos de dna que codifican dichas proteinas y procedimiento para pepararlas
AR027246A1 (es) Procedimiento para la preparacion de acetil-amidiniofenilalanil-ciclohexilglicil-piridinioalaninamidas.
BR0215274A (pt) Alimentos ricos em netionina modificados e processos de sua fabricação
DE60114778D1 (de) Behandlung von infektionen in tieren
ATE293891T1 (de) Verfahren zur herstellung von futterstücken aus klärschlamm

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009